WinstonWınston
Back
Afya Limited logo

Afya Limited

AFYA
77
Education & Training Services · Consumer Defensive
Exchange
NASDAQ
Winston Score
77
Winston is happy
A high-quality business with solid fundamentals.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Strong
Growth
Strong
Cash Flow
Exceptional
Stability
Good
Valuation
Strong
Dividends
Good

Winston Score History

The full picture

Afya Limited is a Brazilian company that trains doctors. It runs medical schools and digital learning tools aimed at students who want to become physicians in Brazil. Afya is the largest medical education group in Brazil, serving tens of thousands of medical students across dozens of campuses nationwide.

Afya makes money by charging tuition to medical students, both through in-person degree programs and digital subscription products that help students study for licensing exams. It operates entirely in Brazil, where demand for doctors is high and the government tightly controls how many medical school seats exist — that limited supply of seats acts as a natural barrier against new competitors. The key growth driver is Brazil's ongoing shortage of physicians, which keeps demand for medical education strong, but the main risk is regulatory change, since the Brazilian government controls medical school licensing and could alter the rules that currently protect Afya's market position.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.1% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+19.5% YoY

YoY Growth Rate

Steady EPS growth

Insider Activity

72.9%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$1.1B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Afya Limited is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
61.6%
Premium pricing power — 61.6% gross margin
Profit after running costs
Operating Margin
30.1%
Excellent — 30.1% operating margin
Return on the money invested
ROCE
17.7%
Strong — 17.7% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+8.4%
Steady sales growth (+8.4% YoY)
Profit growth
EPS YoY
+14.0%
Earnings growing (+14.0% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is
EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
169%
Turns 169% of profit into real cash
Spare cash per sale
FCF Margin
30.2%
Converts sales into free cash efficiently (30.2%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.43
Conservative — low debt load (0.43)
Covers its interest
Interest Cover
2.50x
Tight — interest eats into profit (2.5x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
8.4x
no trend
Attractive valuation — P/E 8.4

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
+0.8
GROWING
Earnings roughly flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
4.60%
no trend
Healthy income — 4.60% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record
Dividend Growth
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial